Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - indometacin sodium trihydrate -

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

medtas pty ltd - indometacin sodium trihydrate, quantity: 1.061 mg (equivalent: indometacin, qty 1 mg) - injection, powder for - excipient ingredients: - indomethacin ch is indicated for the closure of patent ductus arteriosus in premature babies. clear-cut clinical evidence of a haemodynamically significant patent ductus arteriosus should be present, such as respiratory distress, a continuous murmur, a hyperactive precordium, cardiomegaly and pulmonary plethora on chest x-ray. this product should only be used in a hospital under supervision of a specialist neonatologist.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - indometacin sodium trihydrate -

Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

viatris limited - indometacin sodium trihydrate 1.061mg equivalent to indomethacin 1 mg - powder for injection - 1 mg - active: indometacin sodium trihydrate 1.061mg equivalent to indomethacin 1 mg - indomethacin is indicated for the closure of patent ductus arteriosus in premature babies. clear-cut clinical evidence of a haemodynamically significant patent ductus arteriosus should be present, such as respiratory distress, a continuous murmur, a hyperactive precordium, cardiomegaly and pulmonary plethora on chest x-ray. indomethacin should only be used in a hospital under supervision of a specialist neonatologist.

Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

viatris limited - indometacin sodium trihydrate 1.061mg equivalent to indomethacin 1 mg - powder for injection - 1 mg - active: indometacin sodium trihydrate 1.061mg equivalent to indomethacin 1 mg - indomethacin is indicated for the closure of patent ductus arteriosus in premature babies. clear-cut clinical evidence of a haemodynamically significant patent ductus arteriosus should be present, such as respiratory distress, a continuous murmur, a hyperactive precordium, cardiomegaly and pulmonary plethora on chest x-ray. indomethacin should only be used in a hospital under supervision of a specialist neonatologist.

Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

lundbeck pharmaceuticals ireland - indometacin sodium trihydrate - pdr for soln for injection - 1 milligram

Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - indometacin sodium trihydrate 1.25mg equivalent to 1 mg indomethacin - powder for injection - 1 mg - active: indometacin sodium trihydrate 1.25mg equivalent to 1 mg indomethacin

Ηνωμένο Βασίλειο - Αγγλικά - MHRA (Medicines & Healthcare Products Regulatory Agency)

sandoz ltd - indometacin - oral capsule - 50mg

Ηνωμένο Βασίλειο - Αγγλικά - MHRA (Medicines & Healthcare Products Regulatory Agency)

almus pharmaceuticals ltd - indometacin - oral capsule - 50mg

Ηνωμένο Βασίλειο - Αγγλικά - MHRA (Medicines & Healthcare Products Regulatory Agency)

phoenix healthcare distribution ltd - indometacin - oral capsule - 50mg